9000180009900198009900198001080021600
5T/box(Ⅰ-01)10T/box(Ⅰ-02)5T/box(Ⅱ-01)10T/box(Ⅱ-02)5T/box(Ⅲ-01)10T/box(Ⅲ-02)5T/box(Ⅳ-01)10T/box (IV-02)

9000180009900198009900198001080021600
5T/box(Ⅰ-01)10T/box(Ⅰ-02)5T/box(Ⅱ-01)10T/box(Ⅱ-02)5T/box(Ⅲ-01)10T/box(Ⅲ-02)5T/box(Ⅳ-01)10T/box (IV-02)
Transmembrane-serine protease gene 2 (TMPRSS2) is fused with Erythroblasttransformation-specific (ETS) genes (ERG, ETV1 and ETV4), which are the most common genetic variants in prostate cancer. TMPRSS2, ERG, ETV1 and ETV4 are the most common genetic variants in prostate cancer, and the combination of TMPRSS2, ERG, ETV1 and ETV4 has a good value in the diagnosis and differential diagnosis of prostate cancer, and can be used as a new molecular marker for prostate cancer.